ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
RNS Announcements
Live Quote
 
 

09 Mar 2010

05 Mar 2010

26 Feb 2010

16 Feb 2010
ValiRx Issue of Equity [56.1 kb] PDF

29 Jan 2010

19 Jan 2010
ValiRx GeneICE update [168.4 kb] PDF

13 Jan 2010
ValiRx Issue of Equity [161.7 kb] PDF

< Previous | Page 1 of 14 | Next >